CTOR

Price Data

Citius Oncology, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative cancer therapies for underserved patient populations. The company boasts a diverse pipeline of proprietary technologies aimed at enhancing treatment efficacy and safety across multiple cancer indications. By establishing strategic partnerships and adhering to stringent clinical research standards, Citius Oncology is positioned to advance its promising drug candidates through pivotal clinical trials and regulatory approvals, all while striving to significantly improve patient outcomes in the oncology landscape.